Remote Patient Monitoring Market Share 2023-2028, Size, Industry Analysis, Trends and Forecast

Comments · 6 Views

The global remote patient monitoring market size reached US$ 1.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2028, exhibiting a growth rate (CAGR) of 15.4% during 2023-2028.

IMARC Group, a leading market research company, has recently releases report titled “Remote Patient Monitoring Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global remote patient monitoring market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How big is the remote patient monitoring market?

The global remote patient monitoring market size reached US$ 1.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2028, exhibiting a growth rate (CAGR) of 15.4% during 2023-2028.

The global remote patient monitoring (RPM) represents a subset of telehealth that utilizes digital technologies to collect medical and other forms of data regarding the patient outside the healthcare setting. This information generally comprises blood pressure, blood sugar, weight, blood oxygen levels, heart rate, and electrocardiograms, which are transmitted to medical providers using a telehealth computer system and software that can be installed on a smartphone, computer, and tablet. RPM aids healthcare professionals in monitoring the condition and improving the quality of care given to patients from anywhere across the globe. As a result, this technique finds widespread applications in hospitals, homecare settings, and clinics.

Request Free Sample Report:

Market Trends:

The escalating demand for this technique by healthcare providers across countries to observe patients with mild symptoms and provide hospital-based care on a timely basis, on account of the sudden outbreak of the COVID-19 pandemic, is among the primary factors driving the remote patient monitoring market. Besides this, the elevating prevalence of cardiovascular diseases and the rising geriatric population, which is more susceptible to chronic conditions, are further augmenting the market growth. Moreover, the development of RPM by the leading players that allows real-time video interaction between the patient and the healthcare provider, and the introduction of innovative variants are also catalyzing the global market. Apart from this, the expanding healthcare infrastructure, various advancements in wireless technologies, and the increasing penetration of smartphones are shifting medical services from clinic-centric to patient-centric delivery models, which are acting as significant growth-inducing factors. Furthermore, the launch of the G6 CGM device, a small sensor for measuring glucose levels and sending the data wirelessly to a display device through a transmitter, is anticipated to propel the remote patient monitoring market over the forecasted period.

Ask Analyst and Browse Full Report with TOC List of Figure:

List of Key Companies Covered in this Market Report:

  • Abbott Laboratories (NYSE: ABT)
  • AMD Global Telemedicine Inc.
  • Boston Scientific Corporation (NYSE: BSX)
  • Dexcom, Inc. (NASDAQ: DXCM)
  • GE Healthcare Inc. (Danaher Corporation) (NYSE: GE)
  • Honeywell International Inc. (NYSE: HON)
  • Koninklijke Philips N.V. (AMS: PHIA)
  • Medtronic Inc. (NYSE: MDT)
  • Nihon Kohden Corporation (TYO: 6849)
  • OSI Systems Inc. (NASDAQ: OSIS)
  • Roche Holding AG (SWX: RO)

The report has segmented the market on the basis of device type, application, end-use and geography.

Breakup by Device Type:

  • Blood Pressure Monitor
  • Glucose Monitor
  • Heart Rate Monitor
  • Pulse Oximeters
  • Respiratory Monitor
  • Others

Breakup by Application:

  • Cancer Treatment
  • Cardiovascular Diseases Treatment and Monitoring
  • Diabetes Treatment
  • Sleep Disorder Treatment
  • Weight Management and Fitness Monitoring
  • Others

Breakup by End-Use:

  • Hospitals and Clinics
  • Homecare Settings
  • Others

Breakup by Geography:

  • North America (U.S. Canada)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
  • Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
  • Latin America (Brazil, Mexico)
  • Middle East Africa

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal